The UK government is consulting on highly anticipated amendments to the antitrust legislative framework. Its proposals are aimed at delivering economic growth by supporting the Competition and Markets Authority (CMA)’s 4Ps...more
1/27/2026
/ Algorithms ,
Antitrust Provisions ,
Competition Authorities ,
Consumer Protection Laws ,
Digital Markets Strategy ,
Merger Controls ,
Merger Reviews ,
New Legislation ,
Proposed Legislation ,
Regulatory Reform ,
Threshold Requirements ,
UK ,
UK Competition and Markets Authority (CMA)
The UK Competition and Markets Authority (CMA) has been granted a warrant to search the home of a managing director who denied using his personal phone for work purposes during a dawn raid at his company’s premises.
...more
1/16/2026
/ Anticompetitive Behavior ,
Antitrust Investigations ,
Bid Rigging ,
Competition ,
Competition Authorities ,
Dawn Raids ,
Enforcement Actions ,
Invasion of Privacy ,
Misleading Statements ,
UK ,
UK Competition and Markets Authority (CMA) ,
UK Competition Appeal Tribunal (CAT)
The UK Competition and Markets Authority (CMA) has been granted a warrant to search the home of a managing director who denied using his personal phone for work purposes during a dawn raid at his company’s premises....more
The Court of Justice of the European Union (CJEU) has upheld a General Court (GC) judgment that sided with the European Commission (EC)’s decision to fine Teva and Cephalon for a ‘pay for delay’ pharmaceutical patent...more
12/1/2025
/ Antitrust Litigation ,
Antitrust Violations ,
Competition ,
Court of Justice of the European Union (CJEU) ,
Enforcement Actions ,
EU ,
European Commission ,
Generic Drugs ,
Patent Litigation ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Settlement Agreements
Welcome to our inaugural Life sciences and healthcare insights report, where our global team share their insights on the most important commercial, legal, and regulatory issues facing life sciences and healthcare companies...more
9/18/2025
/ Artificial Intelligence ,
Biologics ,
Compliance ,
Cybersecurity ,
Data Privacy ,
Generic Drugs ,
Health Care Providers ,
Healthcare ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Requirements
From shifts in merger review to significant abuse of dominance fines from the European Commission, we round up the most important recent events in the antitrust space that life sciences companies should be aware of....more
The U.K. Competition Appeal Tribunal (CAT) has imposed its own fines on Pfizer and Flynn Pharma for abusing their dominant positions by charging excessive and unfair prices for phenytoin sodium, an anti-epilepsy drug, after...more
On October 31, 2024, the European Commission (EC) fined Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Europe BV (Teva) EUR462.6 million for abusing a dominant position in several EU Member States on the...more
11/6/2024
/ Antitrust Violations ,
Competition ,
Corporate Counsel ,
Disparagement ,
EU ,
European Commission ,
Fines ,
Infringement ,
Innovation Patent ,
Patents ,
Pharmaceutical Industry ,
Technology Sector ,
Teva Pharmaceuticals ,
UK
This newsletter is a summary of the antitrust developments we think are most interesting to your business. James Webber (partner based in London) and Jess Bowring (counsel based in London) are our editors this month. They...more
9/30/2024
/ Acquisitions ,
Antitrust Division ,
Antitrust Litigation ,
Competition ,
Corporate Governance ,
Draft Guidance ,
EU ,
European Commission ,
European Court of Justice (ECJ) ,
Global Dealmaking ,
Merger Controls ,
Mergers ,
Regulatory Agenda ,
Regulatory Requirements ,
Threshold Requirements ,
UK
Collaboration within an industry can only go as far as competition law will permit. In practice, where the application of competition law is unclear, collaboration will often only go as far as is comfortable for the most...more
The European Commission (EC) has published its latest report on competition enforcement in medicines and medical products.
Key takeaways are that:
EU and Member State authorities imposed multiple material antitrust...more
The UK Competition and Markets Authority (CMA) has taken the unusual step of issuing a prioritisation statement on cooperation between competitors to make combination therapies available to the NHS.
The CMA worked closely...more
The European Commission (EC) has fined five pharmaceutical companies a total of EUR13.4 million for participating in a cartel concerning N-Butylbromide Scopolamine/Hyoscine (SNBB) – an active pharmaceutical ingredient (API)...more
10/23/2023
/ Cartels ,
Cephalon ,
Competition ,
Corporate Counsel ,
EU ,
European Commission ,
Generic Drugs ,
Life Sciences ,
Patents ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Teva Pharmaceuticals
The UK Competition and Markets Authority (CMA) has published its final Green Agreements Guidance on how UK antitrust rules apply to green cooperation agreements between competitors (UK Green Guidance).
The UK Green Guidance...more
10/19/2023
/ Antitrust Division ,
Antitrust Provisions ,
Climate Change ,
Competition ,
Environmental Social & Governance (ESG) ,
EU ,
New Guidance ,
Popular ,
Sustainability ,
UK ,
UK Competition and Markets Authority (CMA)
The European Commission (EC) and the UK Competition and Markets Authority (CMA) have published new guidance on the assessment of cooperation between competitors. For the EU, this is contained in revised Guidelines on...more
9/13/2023
/ Acquisitions ,
Antitrust Provisions ,
Competition ,
EU ,
Horizontal Agreements ,
Information Sharing ,
Mergers ,
New Guidance ,
Regulatory Agenda ,
UK ,
UK Competition and Markets Authority (CMA)
On 1 June 2023, the European Commission (EC) adopted revised Horizontal Block Exemption Regulations on research & development agreements (R&D BER) and specialisation agreements (Specialisation BER) (jointly referred to as...more
6/14/2023
/ Algorithms ,
Anti-Competitive ,
Competition ,
Cooperation Agreement ,
Data-Sharing ,
EU ,
European Commission ,
Exemptions ,
Horizontal Agreements ,
National Security Agency (NSA) ,
Popular ,
Sustainability ,
Treaty on the Functioning of the European Union (TFEU)
Following publication in the EU Official Journal, the Digital Markets Act (DMA, Regulation (EU) 2022/1925) officially entered into force on 1 November 2022.
The DMA introduces new rules for the digital economy. In...more
Nearly a year after the UK Competition and Markets Authority (CMA) announced its Sustainability Taskforce, it has issued for consultation draft guidance to show how businesses can pursue green cooperation without fear of...more
Following publication in the EU Official Journal, the Digital Markets Act (DMA, Regulation (EU) 2022/1925) officially entered into force on 1 November 2022.
The DMA introduces new rules for the digital economy. In...more
The European Parliament and the Council of the EU have adopted the final text of the Digital Markets Act (DMA), which will introduce new rules for the digital economy.
...more
On 10 May 2022, the UK Government announced that it intends to legislate on measures to promote competition, strengthen consumer rights and protect households and businesses as part of its Digital Markets, Competition and...more
The Council of the EU and the European Parliament have reached a provisional political agreement on the Digital Markets Act (DMA), which will impose significant obligations on online platforms that act as ‘gatekeepers’.
...more
Since the UK’s Competition and Markets Authority (CMA) published its Digital Markets Strategy in 2019 (see our alert on its 2019 priorities) it has completed many of the priority tasks it had assigned itself – including...more
The European Commission (EC) has published its draft Digital Markets Act (DMA), which will introduce broad reforms to the application of EU competition law to ‘gatekeepers’ in the digital sector. The proposals set out...more
On 8 December 2020, the UK Digital Markets Taskforce published its recommendations to the UK Government on the possible design and implementation of a new regulatory regime to govern the behaviour of digital firms with market...more